1.Pediatric and Parents' Attitudes Towards COVID-19 Vaccines and Intention to Vaccinate for Children
Soo-Han CHOI ; Yoon Hee JO ; Kyo Jin JO ; Su Eun PARK
Journal of Korean Medical Science 2021;36(31):e227-
Background:
Coronavirus disease 2019 (COVID-19) vaccination is necessary to reach herd immunity and essential for mitigating the spread of the pandemic. In May 2021, the US FDA and the EU have expanded the emergency use authorization for a COVID-19 vaccine to children aged 12 to 15. The aim of this study was to investigate parental acceptability of COVID-19 vaccination for their children, factors affecting their acceptability, and children's perceptions of COVID-19 vaccines in Republic of Korea.
Methods:
We conducted a questionnaire survey at two tertiary hospitals from May 25, 2021 to June 3, 2021. Subjects were parents having children under 18 years and children aged 10–18 years.
Results:
Two hundred twenty-six parents and 117 children aged 10–18 years were included in the final analysis. Overall, 76.5% and 64.2% of parents intended to get vaccinated against COVID-19 and intended to have their children vaccinated, respectively. However, only 49.6% of children responded that they would get COVID-19 vaccination. In the multivariate analysis, high confidence in the safety of COVID-19 vaccines (adjusted odds ratio [AOR], 4.87; 95% confidence interval [CI], 1.32–24.12), parents' willingness to vaccinate themselves (AOR, 19.42; 95% CI, 6.85–64.00), and awareness of the need to vaccinate children against COVID-19 (AOR, 13.15; 95% CI, 4.77–41.27) were associated with positive factors intention to vaccinate their children.
Conclusion
This study provides insight into how parents think about the COVID-19 vaccine for their children in South Korea. Our findings could be referenced in establishing a policy for childhood COVID-19 vaccination in the future.
2.Pediatric and Parents' Attitudes Towards COVID-19 Vaccines and Intention to Vaccinate for Children
Soo-Han CHOI ; Yoon Hee JO ; Kyo Jin JO ; Su Eun PARK
Journal of Korean Medical Science 2021;36(31):e227-
Background:
Coronavirus disease 2019 (COVID-19) vaccination is necessary to reach herd immunity and essential for mitigating the spread of the pandemic. In May 2021, the US FDA and the EU have expanded the emergency use authorization for a COVID-19 vaccine to children aged 12 to 15. The aim of this study was to investigate parental acceptability of COVID-19 vaccination for their children, factors affecting their acceptability, and children's perceptions of COVID-19 vaccines in Republic of Korea.
Methods:
We conducted a questionnaire survey at two tertiary hospitals from May 25, 2021 to June 3, 2021. Subjects were parents having children under 18 years and children aged 10–18 years.
Results:
Two hundred twenty-six parents and 117 children aged 10–18 years were included in the final analysis. Overall, 76.5% and 64.2% of parents intended to get vaccinated against COVID-19 and intended to have their children vaccinated, respectively. However, only 49.6% of children responded that they would get COVID-19 vaccination. In the multivariate analysis, high confidence in the safety of COVID-19 vaccines (adjusted odds ratio [AOR], 4.87; 95% confidence interval [CI], 1.32–24.12), parents' willingness to vaccinate themselves (AOR, 19.42; 95% CI, 6.85–64.00), and awareness of the need to vaccinate children against COVID-19 (AOR, 13.15; 95% CI, 4.77–41.27) were associated with positive factors intention to vaccinate their children.
Conclusion
This study provides insight into how parents think about the COVID-19 vaccine for their children in South Korea. Our findings could be referenced in establishing a policy for childhood COVID-19 vaccination in the future.
3.Stevens-Johnson Syndrome as a Side Effect of Topical Immunotherapy with Diphenylcyclopropenone.
Kyoung Pyo HAN ; Sun Young LEE ; Young Jo KIM ; Kyu Chul CHOI
Korean Journal of Dermatology 1998;36(2):326-330
Topical immunotherapy with diphenylcyclopropenone(DPCP) has been used for the treatment of alopecia areata. Due to the therapeutic principle of producing a contact eczema, itching, erythema and scaling are inevitable or even desired side effects. However, erythema multiforme-like reactions following topical DPCP treatment have been rarely reported with an estimated incidence of 1.2%. We present herein a case of Stevens-Johnson syndrome, the severe form of erythema multiforme as a side effect of topical DPCP. A 57-year old male patient visited us for the treatment of alopecia totalis. After sensitization with 0.2% DPCP in acetone, we applied DPCP on the scalp once a week for three weeks. Following the 3rd challenge of DPCP, iris-shaped lesions, erosions, vesicles, and bullae developed with fever. Also, he had vesicles and erosions in the oral cavity. The patient was treated with systemic antibiotics, steroids, and antihistamines. The cutaneous lesions were cleared with hyperpigmentation, and pronounced hair regrowth was observed.
Acetone
;
Alopecia
;
Alopecia Areata
;
Anti-Bacterial Agents
;
Dermatitis, Contact
;
Erythema
;
Erythema Multiforme
;
Fever
;
Hair
;
Histamine Antagonists
;
Humans
;
Hyperpigmentation
;
Immunotherapy*
;
Incidence
;
Male
;
Middle Aged
;
Mouth
;
Pruritus
;
Scalp
;
Steroids
;
Stevens-Johnson Syndrome*
4.Clinical observation of the diabetes mellitus control and tuberculosis treatment.
Yong Hang AHN ; Hae Jung KIM ; Eun Yun JO ; Nan Kyung YANG ; Han Na CHOI
Journal of the Korean Academy of Family Medicine 1991;12(12):20-24
No abstract available.
Diabetes Mellitus*
;
Tuberculosis*
5.The clinical study of the temporal bone fractures.
Yong Ki KIM ; Sung Chan KIM ; Hyung Ook PARK ; Han Jo NA ; Bong Nam CHOI
Korean Journal of Otolaryngology - Head and Neck Surgery 1992;35(1):67-74
No abstract available.
Temporal Bone*
6.A Case Report for Severe COVID-19 in a 9-Year-Old Child Treated with Remdesivir and Dexamethasone
Yoon Hee JO ; Yosub HWANG ; Soo-Han CHOI
Journal of Korean Medical Science 2021;36(29):e203-
Coronavirus disease 2019 (COVID-19) is generally milder in children than in adults, and a substantial proportion of children with the disease have asymptomatic infections.Remdesivir is recommended for severe COVID-19. To date, there are little data on the outcomes of remdesivir treatment in children. We report a case of severe COVID-19 in a previously healthy but obese (body mass index, 27.6; 99.8 th percentile of the age) 9-year-old boy treated with remdesivir and dexamethasone. The patient had pneumonia at the time of diagnosis and required supplemental oxygen due to hypoxia one day after diagnosis. The patient developed respiratory distress as his pneumonia progressed rapidly. Therefore, remdesivir with dexamethasone therapy was initiated on hospital day 2. Supplemental oxygen was gradually weaned on hospital day 6 and stopped on hospital day 9. Significant improvement in pneumonic consolidations on chest X-ray was noted on hospital day 8. The patient was discharged on hospital day 21. We did not observe any adverse effects of remdesivir therapy and successfully treated a 9-year-old child with severe COVID-19.
7.A Case Report for Severe COVID-19 in a 9-Year-Old Child Treated with Remdesivir and Dexamethasone
Yoon Hee JO ; Yosub HWANG ; Soo-Han CHOI
Journal of Korean Medical Science 2021;36(29):e203-
Coronavirus disease 2019 (COVID-19) is generally milder in children than in adults, and a substantial proportion of children with the disease have asymptomatic infections.Remdesivir is recommended for severe COVID-19. To date, there are little data on the outcomes of remdesivir treatment in children. We report a case of severe COVID-19 in a previously healthy but obese (body mass index, 27.6; 99.8 th percentile of the age) 9-year-old boy treated with remdesivir and dexamethasone. The patient had pneumonia at the time of diagnosis and required supplemental oxygen due to hypoxia one day after diagnosis. The patient developed respiratory distress as his pneumonia progressed rapidly. Therefore, remdesivir with dexamethasone therapy was initiated on hospital day 2. Supplemental oxygen was gradually weaned on hospital day 6 and stopped on hospital day 9. Significant improvement in pneumonic consolidations on chest X-ray was noted on hospital day 8. The patient was discharged on hospital day 21. We did not observe any adverse effects of remdesivir therapy and successfully treated a 9-year-old child with severe COVID-19.
8.Prior Exposure of Mice to Fusobacterium Nucleatum Modulates Host Response to Porphyromonas Gingivalis.
Han Yong SON ; Sung Jo KIM ; Jeom Il CHOI
The Journal of the Korean Academy of Periodontology 2000;30(3):675-685
Multiple periodontal pathogens sequentially colonize the subgingival niche during the conversion from gingivitis to destructive periodontal disease. An animal model of sequential immunization with key periodontal pathogens has been developed to determine whether T and B lymppocyte effector functions are skewed and fail to protect the host from pathogenic challenge. The present study was performed to evaluate immunomodulatory effect of exposure to Fusobacterium nucleatum(F. nucleatum) prior to Porphyromonas gingivalis(P.gingivalis). Group 1(control) mice were immunized with phosphate-buffered saline, Group 2 were immunized with F. nucleatum prior to P. gingivalis, while Group 3 were immunized P. gingivalis alone. All the T cell clones derived from Group 2 demonstrated type 2 helper T cell clone(Th2 subsets), while those from Group 3 mice demonstrated Th1 subsets. Exposure of mice to F. nucleatum prior to P. gingivalis interfered with opsonophagocytosis function of sera against P. gingivalis. In adoptive T cell transfer experiments, in vivo protective capacity type 2 helper T cell clones(Th2) from Group 2 was significantly lower than type 1 helper T cell clones(Th1) from Group 3 against the lethal dose infection of P. gingivalis. Western blot analysis indicated the different pattern of recognition of P. gingivalis fimbrial proteins between sera from Group 2 and Group 3. In conclusion, these study suggest that colonization of the subgingival niche by F. nucleatum prior to the periodontal pathogen, P. gingivalis, modulates the host immune responses to P. gingivalis at humoral, cellular and molecular levels.
Animals
;
Blotting, Western
;
Clone Cells
;
Colon
;
Fusobacterium nucleatum*
;
Fusobacterium*
;
Gingivitis
;
Immunization
;
Mice*
;
Models, Animal
;
Periodontal Diseases
;
Porphyromonas gingivalis*
;
Porphyromonas*
9.6 Cases of Primary Obstructive Megaureter.
Sang Jae KANG ; Eui Je JO ; Chang Sup HAN ; Sune Hyup CHOI
Korean Journal of Urology 1989;30(2):219-223
The massively dilated ureter is one of major therapeutic challenges that face the urologists. The goals of reconstructive procedures are the elimination of residual urine, effective ureteral peristalsis, efficient and/or urgent drainage. 6 cases of primary obstructive megaureter were presented with review of literatures. The results obtained were as follows ; 1. 6 cases were divided into 2 groups according to etiology with 4 adynamic segments and 2 intrinsic stenosis. 2. The underlying histopathologic features included 1 submucosal inflammation,2 submucosal fibrosis with inflammation and 2 submucosal fibrosis. 3. 5 cases were treated with Hendren's technique and 1 case treated by ureteral meatotomy. 4. All cases showed obvious improvement of upper tract without complication during follow-up period from 5 to 26 months.
Constriction, Pathologic
;
Drainage
;
Fibrosis
;
Follow-Up Studies
;
Inflammation
;
Peristalsis
;
Ureter
10.Acute Pulmonar Edema during General Anesthesia.
Kwang Whan WHANG ; Byung Jo CHOI
Korean Journal of Anesthesiology 1974;7(1):141-144
The authors have experienced, during general anesthesia with methoxyflurane-nitrous oxide- oxygen for explorative laparatomy to perform appendectomy, a case of acute pulmonary edema, which is rare and it's etiology is various. The patient had no specific past or family history and the only predisposing factor was myocardial ischemia caused by cardio-vascular collapse due to severe dehydration. In this case, the authors believed that pre-existing myocardial ischemia, rapid transfusion of 5% dextrose and myocardial depressants (methoxyflurane and d-tubocurarine) were the causative factors. For this reason at least, myocardial depressants should be avoided in severely dehydrated patients. There are many preventive measures and treatments for acute pulmonary edema during general anesthesia. As in this case, we believe that prompt recognition and attention by the anesthesiologists are the most important preventive and therapeutic measures.
Anesthesia, General*
;
Anti-Arrhythmia Agents
;
Appendectomy
;
Causality
;
Dehydration
;
Edema*
;
Glucose
;
Humans
;
Myocardial Ischemia
;
Oxygen
;
Pulmonary Edema